Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV

Abstract Background People living with HIV/AIDS are facing sub-optimal adherence to antiretroviral therapy. Short message service innovative strategies have been recommended by the national strategy to support medication adherence among HIV positive people. Thus, this study was conducted to examine the feasibility and acceptability of a short message service to improve medication adherence among people living with HIV/AIDS receiving Antiretroviral Treatment. Methods We conducted a cross-sectional survey, from February 5 to 30, 2018, among 422 randomly selected adults living with HIV/AIDS receiving antiretroviral treatment at Adama Hospital. Interviewer administered structured questionnaire was used to collect quantitative data on the feasibility and acceptability of short message services, socio-demographic and clinical characteristics of participants. Qualitative data were also collected from two focus groups to supplement the quantitative findings. Logistic regression analysis was performed to identify factors associated with the feasibility and acceptability of short message services. Results Of 420 participants responded to our questionnaire, about nine of ten patients (93.8%) possessed had a mobile phone. Most of the patients (90.9%) were willing to accept SMS to improve their medication adherence. Patients who were in young age, early adult, disclosed their HIV status, having cell phone always and believe short message service aid adherence were more likely to accept short messages on adherence. On the other hand, frequent ART Clinic visit and perceived low confidentiality of short message service were negatively associated with acceptability of short message service. Conclusion The acceptability of short message service on adherence to antiretroviral therapy was high among people living with HIV/AIDS central Ethiopia. Authors recommend further studies, piloting or experimenting, that validate the acceptability, feasibility, effectiveness, and scalability of the intervention.

Download Full-text

Assessing the interaction between depressive symptoms and alcohol use prior to antiretroviral therapy on viral suppression among people living with HIV in Rural Uganda

AIDS Care ◽

10.1080/09540121.2020.1770671 ◽

2020 ◽

Vol 32 (10) ◽

pp. 1251-1257

Author(s):

Jacklyn D. Foley ◽

Alan Sheinfil ◽

Sarah E. Woolf-King ◽

Robin Fatch ◽

Nneka I. Emenyonu ◽

...

Keyword(s):

Depressive Symptoms ◽

Antiretroviral Therapy ◽

Alcohol Use ◽

Viral Suppression ◽

People Living With Hiv ◽

Living With Hiv

Download Full-text

Mood and anxiety disorders adversely influence medication adherence to antiretroviral therapy among people living with HIV/AIDS in Nigeria

HIV & AIDS Review ◽

10.5114/hivar.2018.76368 ◽

2018 ◽

Vol 17 (2) ◽

pp. 91-97 ◽

Cited By ~ 1

Author(s):

Omonefe Seb-Akahomen ◽

Ambrose Lawani ◽

Bawo James

Keyword(s):

Medication Adherence ◽

Antiretroviral Therapy ◽

Anxiety Disorders ◽

People Living With Hiv ◽

Mood And Anxiety Disorders ◽

Living With Hiv ◽

Hiv Aids

Download Full-text

Self-reported changes in alcohol use behavior among people living with HIV in China after receiving HIV positive diagnosis

SAGE Open Medicine ◽

10.1177/2050312118755783 ◽

2018 ◽

Vol 6 ◽

pp. 205031211875578 ◽

Cited By ~ 1

Author(s):

Yan Wang ◽

Xinguang Chen ◽

Jacob Ball ◽

Xiaoming Li ◽

Yuejiao Zhou ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Alcohol Use ◽

Drinking Behavior ◽

Female Gender ◽

People Living With Hiv ◽

Hiv Diagnosis ◽

Large Random Sample ◽

Reduced Drinking ◽

Use Behavior ◽

Living With Hiv

Background: Alcohol use remains a significant challenge for treating people living with HIV (people living with HIV). We aimed to examine current use and retrospective self-reported changes in drinking behavior after HIV+ diagnosis in people living with HIV. Method: Survey data were collected from a large random sample of people living with HIV (N = 2964, mean age = 42.5, standard deviation = 12.8) in Guangxi, China. Results: The estimated prevalence rate of current alcohol use was 42.8%. Among current drinkers, 41.7% reported binge drinking and 10.4% reported hazardous drinking. Among the ever drinkers, 45.4% reported reductions in drinking and 19.5% reported quitting after HIV+ diagnosis. Older age, female gender, higher income, being employed, if currently on antiretroviral therapy, and having received an HIV+ diagnosis within a year were positively associated with quitting; and more education, lower income, currently on antiretroviral therapy, and having received an HIV+ diagnosis more than one year were associated with reduced drinking. Conclusion: The time period immediately following receiving an HIV+ diagnosis may represent a window of opportunity for alcohol use intervention in people living with HIV.

Download Full-text

Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam

AIDS ◽

10.1097/qad.0000000000002716 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Jennifer A. Wagman ◽

Adriane Wynn ◽

Mika Matsuzaki ◽

Natalia Gnatienko ◽

Lisa R. Metsch ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Alcohol Use ◽

Viral Suppression ◽

People Living With Hiv ◽

Hazardous Alcohol Use ◽

Hazardous Alcohol ◽

Living With Hiv ◽

The U.S

Download Full-text

Medication adherence to antiretroviral therapy among newly treated people living with HIV

BMC Public Health ◽

10.1186/s12889-018-5731-z ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 11

Author(s):

Yang Yu ◽

Dan Luo ◽

Xi Chen ◽

Zhulin Huang ◽

Min Wang ◽

...

Keyword(s):

Medication Adherence ◽

Antiretroviral Therapy ◽

People Living With Hiv ◽

Living With Hiv

Download Full-text

Metabolic Syndrome in HIV-patients in Antiretroviral Therapy

Current HIV Research ◽

10.2174/1570162x18666200609115615 ◽

2020 ◽

Vol 18 (6) ◽

pp. 388-395

Author(s):

Daniel Vargas-Pacherrez ◽

Helma P. Cotrim ◽

Leonardo Pires ◽

Vitor Cunha ◽

Vitor Coelho ◽

...

Keyword(s):

Metabolic Syndrome ◽

Antiretroviral Therapy ◽

International Diabetes Federation ◽

Cross Sectional Study ◽

People Living With Hiv ◽

Anthropometric Data ◽

Cross Sectional ◽

History Of ◽

Family History Of Hypertension ◽

Living With Hiv

Introduction: The global prevalence of metabolic syndrome (MS) among people living with HIV/AIDS varies from 20% to 33%. Objective: to estimate the prevalence of metabolic syndrome and associated factors in a group of HIV-infected patients on antiretroviral therapy. Methods: This is a cross-sectional study with HIV-infected patients from a reference center in Bahia, Brazil. We evaluated clinical, socio-demographic and anthropometric data. MS was defined according to the guidelines of International Diabetes Federation. Results: We evaluated 152 patients with mean age of 47.3±11.6 years, 59.2% male. The main comorbidities detected were diabetes (3.3%) hypertriglyceridemia (9.3%) and metabolic syndrome (MS,38.2%). Patients with MS were predominantly women (55.2% vs 31.9%; p=0.005), older [52.1 (10.4) vs 44.3 (11.3); p<0.001], and had overweight (74.1% vs 23.4%; p<0.001). After multivariate analysis MS remained associated with age (OR = 1.076; 95% CI: 1.030 – 1.125), female sex (OR = 2.452; 95% CI: 1.114 – 5.374) and family history of hypertension (OR = 3.678; 95% CI: 1.431 – 9.395). Conclusion: Almost half of the HIV-infected patients in Bahia presents with MS which seems to be driven by classical risk factors.

Download Full-text